Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:36:05.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, with a standard header and footer, indicating access to the study record is blocked.
    Difference
    18%
    Check dated 2026-09-20T19:44:17.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study document revision was updated to v3.6.6 with two new update dates (2026-08-24 and 2026-08-05) and a revised file size of 1.86MB, reflecting changes to the attached document and its metadata.
    Difference
    0.2%
    Check dated 2026-08-30T22:23:10.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5 in place of Revision: v3.6.4. This indicates a software/markup update to the study page.
    Difference
    0.0%
    Check dated 2026-08-09T11:07:55.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a minor update to the page template or documentation. This update does not affect the study content or data.
    Difference
    0.0%
    Check dated 2026-07-25T18:02:14.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The revision label now reads v3.6.3 where it previously showed v3.6.2. This update reflects a small metadata version change and does not modify the study details.
    Difference
    0.0%
    Check dated 2026-07-04T13:35:46.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.